---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-073129"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2024-08-28T23:59:59+00:00"
generated_at: "2026-05-31T07:14:19.027356+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Envoy Medical secures $10M lending facility from majority shareholder Glen Taylor; draws $5M

## Summary
- Unsecured Note with 8% interest, 5-year term; interest deferred for first 2 years.
- Initial draw of $5M; issued warrants for 500,000 shares at $2.97 per share.
- Funds to support Acclaim fully implanted cochlear implant IDE and pivotal study.
- Glen Taylor is a director and controlling stockholder; facility is non-convertible.
- Up to $10M available in $2.5M tranches; no prepayment penalty.

## SEC filing metadata
- accession: 0001213900-24-073129
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2024-08-28T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000121390024073129/0001213900-24-073129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000121390024073129/ea0212623-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-073129
- JSON: https://secwatch.observer/filing/0001213900-24-073129.json
- Plain text: https://secwatch.observer/filing/0001213900-24-073129.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
